Cover Image

EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY

Effect of hyperlipidemia on morbidity and mortality in elderly patients is considered. Authors also cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention of cardiovascular diseases in patients ≥80 years of age who are the most quickly growing group of popu...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Ushkalova (Author), O. N. Tkacheva (Author), N. K. Runikhina (Author), N. A. Chukhareva (Author), A. Yu. Bevz (Author)
Format:	Book
Published:	Столичная издательская компания, 2016-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features of pharmacotherapy in the elderly patients. Introduction to the problem
by: E. A. Ushkalova, et al.
Published: (2016)

PHARMACOTHERAPY OF ARTERIAL HYPERTENSION IN ELDERLY PATIENTS: FOCUS ON OCTOGENARIANS
by: E. A. Ushkalova, et al.
Published: (2016)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015)

Revisiting the Safety of Vaccination against the Flu in Elderly Patients
by: O. N. Tkacheva, et al.
Published: (2018)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015)

Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs
by: E. A. Ushkalova, et al.
Published: (2016)

Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs
by: E. A. Ushkalova, et al.
Published: (2016)

Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study
by: Noorhida Baharudin, et al.
Published: (2022)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015)

LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)
by: N. M. Akhmedzhanov, et al.
Published: (2016)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019)

Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding
by: N. M. Vorobyeva, et al.
Published: (2023)

Lipid Clinic is an Efficacious Model of Preventive Medicine
by: A. V. Blokhina, et al.
Published: (2021)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
by: Xie W, et al.
Published: (2019)

The role of iodine deficiency in women's reproductive health
by: R M Yesayan, et al.
Published: (2013)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023)

THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017)

Cardiovascular risk and the possibility of its correction in women with premature ovarian insufficiency
by: A. A. Pozdnyakova, et al.
Published: (2019)

Possible Approaches to Primary Prevention of Cardiovascular Diseases
by: V. N. Larina, et al.
Published: (2020)

Arterial'naya gipertenziya u beremennykh
by: O N Tkacheva, et al.
Published: (2009)

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
by: Diana N. Vikulova, et al.
Published: (2020)

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
by: Fragoulakis V, et al.
Published: (2012)

Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident
by: S. A. Boytsov, et al.
Published: (2022)

Algoritmy diagnostiki i lecheniyaarterial'noy gipertenziiu beremennykh
by: O N Tkacheva, et al.
Published: (2010)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015)

Geriatric syndrome of falls in comorbid patients: paradox of normotension in the elderly
by: Olga N. Tkacheva, et al.
Published: (2022)

Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023)

Efficacy, safety and Cardiovascular Disease Risk Lowering Ability of ACE Inhibitors, Î²-Blockers and Combination Antihypertensive Drug Regimes in Iraq
by: Dlveen M. Sulaiman, et al.
Published: (2017)

Efficacy, safety and Cardiovascular Disease Risk Lowering Ability of ACE Inhibitors, B-Blockers and Combination Antihypertensive Drug Regimes in Iraq
by: Dlveen M. Sulaiman, et al.
Published: (2017)

GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS
by: M. A. Vorobyeva, et al.
Published: (2017)

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024)

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease
by: article Editorial
Published: (2023)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016)

COMMENTS ON GUIDELINES OF THE TASK FORCE ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF EUROPEAN SOCIETY OF CARDIOLOGY
by: O. N. Tkacheva
Published: (2016)

Efficacy and Safety of Text Messages Targeting Adherence to Cardiovascular Medications in Secondary Prevention: TXT2HEART Colombia Randomized Controlled Trial
by: Anderson Bermon, et al.
Published: (2021)